,address1,address2,city,state,zip,country,phone,website,industry,industryDisp,sector,sectorDisp,longBusinessSummary,companyOfficers,compensationAsOfEpochDate,maxAge,priceHint,previousClose,open,dayLow,dayHigh,regularMarketPreviousClose,regularMarketOpen,regularMarketDayLow,regularMarketDayHigh,payoutRatio,beta,volume,regularMarketVolume,averageVolume,averageVolume10days,averageDailyVolume10Day,bid,ask,bidSize,askSize,marketCap,fiftyTwoWeekLow,fiftyTwoWeekHigh,priceToSalesTrailing12Months,fiftyDayAverage,twoHundredDayAverage,trailingAnnualDividendRate,trailingAnnualDividendYield,currency,enterpriseValue,profitMargins,floatShares,sharesOutstanding,heldPercentInsiders,heldPercentInstitutions,impliedSharesOutstanding,bookValue,priceToBook,lastFiscalYearEnd,nextFiscalYearEnd,mostRecentQuarter,netIncomeToCommon,trailingEps,lastSplitFactor,lastSplitDate,enterpriseToRevenue,enterpriseToEbitda,52WeekChange,SandP52WeekChange,exchange,quoteType,symbol,underlyingSymbol,shortName,longName,firstTradeDateEpochUtc,timeZoneFullName,timeZoneShortName,uuid,messageBoardId,gmtOffSetMilliseconds,currentPrice,recommendationKey,totalCash,totalCashPerShare,ebitda,totalDebt,quickRatio,currentRatio,totalRevenue,debtToEquity,revenuePerShare,returnOnAssets,returnOnEquity,grossProfits,freeCashflow,operatingCashflow,revenueGrowth,grossMargins,ebitdaMargins,operatingMargins,financialCurrency,trailingPegRatio
0,625 Howe Street,Suite 1200,Vancouver,BC,V6C 2M6,Canada,808 650 3007,https://www.abattis.com,Drug Manufacturers—Specialty & Generic,Drug Manufacturers—Specialty & Generic,Healthcare,Healthcare,"Abattis Bioceuticals Corp. operates as a life sciences and biotechnology company in Canada. The company develops and licenses natural health products, medicines, extractions, and ingredients for the biological, nutraceutical, bioceutical, and cosmetic markets. It also provides Comfort, a cannabinoid enhanced nutraceutical for pain and inflammation; and Health-Canada licensed services for the cannabis industry. The company was formerly known as Abattis Biologix Corporation and changed its name to Abattis Bioceuticals Corporation in September 2012. Abattis Bioceuticals Corp. was incorporated in 1997 and is headquartered in Vancouver, Canada.","{'maxAge': 1, 'name': 'Mr. Robert J. Abenante BBA, CA, MPAcc', 'age': 39, 'title': 'Pres, CEO & Director', 'yearBorn': 1983, 'fiscalYear': 2017, 'totalPay': 277930, 'exercisedValue': 0, 'unexercisedValue': 0}",1514678400,86400,4,1e-06,1e-06,1e-06,1e-06,1e-06,1e-06,1e-06,1e-06,0.0,-61.00899,180,180,0,0,0,0.0,0.0,0,0,473026,1e-06,0.0001,1.3254632,1e-05,1e-05,0.0,0.0,USD,-2660757,0.0,475901802,477804000,0.0,0.00017999999,473026002944,0.023,4.347826e-05,1569801600,1601424000,1569801600,-3042005,-0.01,1:5,1347321600,-7.456,0.693,-0.8,0.14113986,PNK,EQUITY,ATTBF,ATTBF,ABATTIS BIOCEUTICALS CORP,Abattis Bioceuticals Corp.,1401370200,America/New_York,EDT,e2904efa-ad1e-3945-a241-307492c2d036,finmb_4049120,-14400000,1e-06,none,2402003,0.005,-3837725,150859,0.525,0.733,356876,1.414,0.001,-0.15941,-0.28129998,241336,-2456610,9412081,90.643,0.67625,0.0,-10.9565,CAD,
1,625 Howe Street,Suite 1200,Vancouver,BC,V6C 2M6,Canada,808 650 3007,https://www.abattis.com,Drug Manufacturers—Specialty & Generic,Drug Manufacturers—Specialty & Generic,Healthcare,Healthcare,"Abattis Bioceuticals Corp. operates as a life sciences and biotechnology company in Canada. The company develops and licenses natural health products, medicines, extractions, and ingredients for the biological, nutraceutical, bioceutical, and cosmetic markets. It also provides Comfort, a cannabinoid enhanced nutraceutical for pain and inflammation; and Health-Canada licensed services for the cannabis industry. The company was formerly known as Abattis Biologix Corporation and changed its name to Abattis Bioceuticals Corporation in September 2012. Abattis Bioceuticals Corp. was incorporated in 1997 and is headquartered in Vancouver, Canada.","{'maxAge': 1, 'name': 'Mr. Francesco  Paolini', 'title': 'CFO & Director', 'exercisedValue': 0, 'unexercisedValue': 0}",1514678400,86400,4,1e-06,1e-06,1e-06,1e-06,1e-06,1e-06,1e-06,1e-06,0.0,-61.00899,180,180,0,0,0,0.0,0.0,0,0,473026,1e-06,0.0001,1.3254632,1e-05,1e-05,0.0,0.0,USD,-2660757,0.0,475901802,477804000,0.0,0.00017999999,473026002944,0.023,4.347826e-05,1569801600,1601424000,1569801600,-3042005,-0.01,1:5,1347321600,-7.456,0.693,-0.8,0.14113986,PNK,EQUITY,ATTBF,ATTBF,ABATTIS BIOCEUTICALS CORP,Abattis Bioceuticals Corp.,1401370200,America/New_York,EDT,e2904efa-ad1e-3945-a241-307492c2d036,finmb_4049120,-14400000,1e-06,none,2402003,0.005,-3837725,150859,0.525,0.733,356876,1.414,0.001,-0.15941,-0.28129998,241336,-2456610,9412081,90.643,0.67625,0.0,-10.9565,CAD,
2,625 Howe Street,Suite 1200,Vancouver,BC,V6C 2M6,Canada,808 650 3007,https://www.abattis.com,Drug Manufacturers—Specialty & Generic,Drug Manufacturers—Specialty & Generic,Healthcare,Healthcare,"Abattis Bioceuticals Corp. operates as a life sciences and biotechnology company in Canada. The company develops and licenses natural health products, medicines, extractions, and ingredients for the biological, nutraceutical, bioceutical, and cosmetic markets. It also provides Comfort, a cannabinoid enhanced nutraceutical for pain and inflammation; and Health-Canada licensed services for the cannabis industry. The company was formerly known as Abattis Biologix Corporation and changed its name to Abattis Bioceuticals Corporation in September 2012. Abattis Bioceuticals Corp. was incorporated in 1997 and is headquartered in Vancouver, Canada.","{'maxAge': 1, 'name': 'Mr. Patrick  Mitchell', 'title': 'COO & Director', 'exercisedValue': 0, 'unexercisedValue': 0}",1514678400,86400,4,1e-06,1e-06,1e-06,1e-06,1e-06,1e-06,1e-06,1e-06,0.0,-61.00899,180,180,0,0,0,0.0,0.0,0,0,473026,1e-06,0.0001,1.3254632,1e-05,1e-05,0.0,0.0,USD,-2660757,0.0,475901802,477804000,0.0,0.00017999999,473026002944,0.023,4.347826e-05,1569801600,1601424000,1569801600,-3042005,-0.01,1:5,1347321600,-7.456,0.693,-0.8,0.14113986,PNK,EQUITY,ATTBF,ATTBF,ABATTIS BIOCEUTICALS CORP,Abattis Bioceuticals Corp.,1401370200,America/New_York,EDT,e2904efa-ad1e-3945-a241-307492c2d036,finmb_4049120,-14400000,1e-06,none,2402003,0.005,-3837725,150859,0.525,0.733,356876,1.414,0.001,-0.15941,-0.28129998,241336,-2456610,9412081,90.643,0.67625,0.0,-10.9565,CAD,
3,625 Howe Street,Suite 1200,Vancouver,BC,V6C 2M6,Canada,808 650 3007,https://www.abattis.com,Drug Manufacturers—Specialty & Generic,Drug Manufacturers—Specialty & Generic,Healthcare,Healthcare,"Abattis Bioceuticals Corp. operates as a life sciences and biotechnology company in Canada. The company develops and licenses natural health products, medicines, extractions, and ingredients for the biological, nutraceutical, bioceutical, and cosmetic markets. It also provides Comfort, a cannabinoid enhanced nutraceutical for pain and inflammation; and Health-Canada licensed services for the cannabis industry. The company was formerly known as Abattis Biologix Corporation and changed its name to Abattis Bioceuticals Corporation in September 2012. Abattis Bioceuticals Corp. was incorporated in 1997 and is headquartered in Vancouver, Canada.","{'maxAge': 1, 'name': 'Mr. Shawn  Balaghi', 'title': 'Head of Corp.  Devel.', 'exercisedValue': 0, 'unexercisedValue': 0}",1514678400,86400,4,1e-06,1e-06,1e-06,1e-06,1e-06,1e-06,1e-06,1e-06,0.0,-61.00899,180,180,0,0,0,0.0,0.0,0,0,473026,1e-06,0.0001,1.3254632,1e-05,1e-05,0.0,0.0,USD,-2660757,0.0,475901802,477804000,0.0,0.00017999999,473026002944,0.023,4.347826e-05,1569801600,1601424000,1569801600,-3042005,-0.01,1:5,1347321600,-7.456,0.693,-0.8,0.14113986,PNK,EQUITY,ATTBF,ATTBF,ABATTIS BIOCEUTICALS CORP,Abattis Bioceuticals Corp.,1401370200,America/New_York,EDT,e2904efa-ad1e-3945-a241-307492c2d036,finmb_4049120,-14400000,1e-06,none,2402003,0.005,-3837725,150859,0.525,0.733,356876,1.414,0.001,-0.15941,-0.28129998,241336,-2456610,9412081,90.643,0.67625,0.0,-10.9565,CAD,
4,625 Howe Street,Suite 1200,Vancouver,BC,V6C 2M6,Canada,808 650 3007,https://www.abattis.com,Drug Manufacturers—Specialty & Generic,Drug Manufacturers—Specialty & Generic,Healthcare,Healthcare,"Abattis Bioceuticals Corp. operates as a life sciences and biotechnology company in Canada. The company develops and licenses natural health products, medicines, extractions, and ingredients for the biological, nutraceutical, bioceutical, and cosmetic markets. It also provides Comfort, a cannabinoid enhanced nutraceutical for pain and inflammation; and Health-Canada licensed services for the cannabis industry. The company was formerly known as Abattis Biologix Corporation and changed its name to Abattis Bioceuticals Corporation in September 2012. Abattis Bioceuticals Corp. was incorporated in 1997 and is headquartered in Vancouver, Canada.","{'maxAge': 1, 'name': 'Mr. Jim  Carter', 'title': 'Head of Mergers and Acquisitions Advisory', 'exercisedValue': 0, 'unexercisedValue': 0}",1514678400,86400,4,1e-06,1e-06,1e-06,1e-06,1e-06,1e-06,1e-06,1e-06,0.0,-61.00899,180,180,0,0,0,0.0,0.0,0,0,473026,1e-06,0.0001,1.3254632,1e-05,1e-05,0.0,0.0,USD,-2660757,0.0,475901802,477804000,0.0,0.00017999999,473026002944,0.023,4.347826e-05,1569801600,1601424000,1569801600,-3042005,-0.01,1:5,1347321600,-7.456,0.693,-0.8,0.14113986,PNK,EQUITY,ATTBF,ATTBF,ABATTIS BIOCEUTICALS CORP,Abattis Bioceuticals Corp.,1401370200,America/New_York,EDT,e2904efa-ad1e-3945-a241-307492c2d036,finmb_4049120,-14400000,1e-06,none,2402003,0.005,-3837725,150859,0.525,0.733,356876,1.414,0.001,-0.15941,-0.28129998,241336,-2456610,9412081,90.643,0.67625,0.0,-10.9565,CAD,
5,625 Howe Street,Suite 1200,Vancouver,BC,V6C 2M6,Canada,808 650 3007,https://www.abattis.com,Drug Manufacturers—Specialty & Generic,Drug Manufacturers—Specialty & Generic,Healthcare,Healthcare,"Abattis Bioceuticals Corp. operates as a life sciences and biotechnology company in Canada. The company develops and licenses natural health products, medicines, extractions, and ingredients for the biological, nutraceutical, bioceutical, and cosmetic markets. It also provides Comfort, a cannabinoid enhanced nutraceutical for pain and inflammation; and Health-Canada licensed services for the cannabis industry. The company was formerly known as Abattis Biologix Corporation and changed its name to Abattis Bioceuticals Corporation in September 2012. Abattis Bioceuticals Corp. was incorporated in 1997 and is headquartered in Vancouver, Canada.","{'maxAge': 1, 'name': 'Mr. Christopher P. Cherry C.A., CPA, CA, CGA, CPA', 'age': 43, 'title': 'Corp. Comptroller', 'yearBorn': 1979, 'exercisedValue': 0, 'unexercisedValue': 0}",1514678400,86400,4,1e-06,1e-06,1e-06,1e-06,1e-06,1e-06,1e-06,1e-06,0.0,-61.00899,180,180,0,0,0,0.0,0.0,0,0,473026,1e-06,0.0001,1.3254632,1e-05,1e-05,0.0,0.0,USD,-2660757,0.0,475901802,477804000,0.0,0.00017999999,473026002944,0.023,4.347826e-05,1569801600,1601424000,1569801600,-3042005,-0.01,1:5,1347321600,-7.456,0.693,-0.8,0.14113986,PNK,EQUITY,ATTBF,ATTBF,ABATTIS BIOCEUTICALS CORP,Abattis Bioceuticals Corp.,1401370200,America/New_York,EDT,e2904efa-ad1e-3945-a241-307492c2d036,finmb_4049120,-14400000,1e-06,none,2402003,0.005,-3837725,150859,0.525,0.733,356876,1.414,0.001,-0.15941,-0.28129998,241336,-2456610,9412081,90.643,0.67625,0.0,-10.9565,CAD,
6,625 Howe Street,Suite 1200,Vancouver,BC,V6C 2M6,Canada,808 650 3007,https://www.abattis.com,Drug Manufacturers—Specialty & Generic,Drug Manufacturers—Specialty & Generic,Healthcare,Healthcare,"Abattis Bioceuticals Corp. operates as a life sciences and biotechnology company in Canada. The company develops and licenses natural health products, medicines, extractions, and ingredients for the biological, nutraceutical, bioceutical, and cosmetic markets. It also provides Comfort, a cannabinoid enhanced nutraceutical for pain and inflammation; and Health-Canada licensed services for the cannabis industry. The company was formerly known as Abattis Biologix Corporation and changed its name to Abattis Bioceuticals Corporation in September 2012. Abattis Bioceuticals Corp. was incorporated in 1997 and is headquartered in Vancouver, Canada.","{'maxAge': 1, 'name': 'Ms. Nicole  Breitinger', 'title': 'Corp. Sec.', 'exercisedValue': 0, 'unexercisedValue': 0}",1514678400,86400,4,1e-06,1e-06,1e-06,1e-06,1e-06,1e-06,1e-06,1e-06,0.0,-61.00899,180,180,0,0,0,0.0,0.0,0,0,473026,1e-06,0.0001,1.3254632,1e-05,1e-05,0.0,0.0,USD,-2660757,0.0,475901802,477804000,0.0,0.00017999999,473026002944,0.023,4.347826e-05,1569801600,1601424000,1569801600,-3042005,-0.01,1:5,1347321600,-7.456,0.693,-0.8,0.14113986,PNK,EQUITY,ATTBF,ATTBF,ABATTIS BIOCEUTICALS CORP,Abattis Bioceuticals Corp.,1401370200,America/New_York,EDT,e2904efa-ad1e-3945-a241-307492c2d036,finmb_4049120,-14400000,1e-06,none,2402003,0.005,-3837725,150859,0.525,0.733,356876,1.414,0.001,-0.15941,-0.28129998,241336,-2456610,9412081,90.643,0.67625,0.0,-10.9565,CAD,
